Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pneumonectomy | 5 | 2024 | 1094 | 0.920 |
Why?
|
Esophagectomy | 2 | 2023 | 447 | 0.810 |
Why?
|
Esophageal Neoplasms | 2 | 2023 | 1582 | 0.790 |
Why?
|
Chest Tubes | 1 | 2021 | 150 | 0.770 |
Why?
|
Mediastinal Diseases | 1 | 2021 | 89 | 0.770 |
Why?
|
Choristoma | 1 | 2021 | 213 | 0.700 |
Why?
|
Single-Chain Antibodies | 3 | 2014 | 108 | 0.700 |
Why?
|
Pancreatic Neoplasms | 9 | 2016 | 5257 | 0.640 |
Why?
|
Esophageal Stenosis | 1 | 2019 | 195 | 0.630 |
Why?
|
Pneumothorax | 1 | 2021 | 379 | 0.630 |
Why?
|
Hernia, Hiatal | 1 | 2018 | 79 | 0.620 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 5 | 2024 | 5221 | 0.460 |
Why?
|
Carcinoembryonic Antigen | 1 | 2014 | 347 | 0.450 |
Why?
|
N-Acetylneuraminic Acid | 1 | 2013 | 177 | 0.440 |
Why?
|
Antibodies, Neoplasm | 1 | 2013 | 286 | 0.420 |
Why?
|
Carcinoma, Pancreatic Ductal | 4 | 2016 | 1634 | 0.400 |
Why?
|
Antibody Specificity | 1 | 2013 | 1095 | 0.400 |
Why?
|
Neoplasm Staging | 10 | 2024 | 11007 | 0.390 |
Why?
|
Receptors, Fc | 1 | 2014 | 541 | 0.380 |
Why?
|
Lung Neoplasms | 7 | 2024 | 13096 | 0.370 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2013 | 694 | 0.370 |
Why?
|
Postoperative Complications | 4 | 2022 | 15294 | 0.310 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2014 | 3557 | 0.300 |
Why?
|
Positron-Emission Tomography | 4 | 2014 | 6274 | 0.280 |
Why?
|
Adenocarcinoma | 3 | 2021 | 6352 | 0.230 |
Why?
|
Quality Indicators, Health Care | 1 | 2012 | 1831 | 0.200 |
Why?
|
Carcinoma, Large Cell | 1 | 2021 | 113 | 0.190 |
Why?
|
Hemoptysis | 1 | 2021 | 155 | 0.180 |
Why?
|
Mediastinum | 1 | 2021 | 267 | 0.180 |
Why?
|
Neoplastic Cells, Circulating | 2 | 2016 | 933 | 0.170 |
Why?
|
Mice, Nude | 3 | 2014 | 3689 | 0.170 |
Why?
|
Rheology | 1 | 2019 | 345 | 0.160 |
Why?
|
Patient Readmission | 1 | 2012 | 3114 | 0.160 |
Why?
|
Fundoplication | 1 | 2018 | 138 | 0.150 |
Why?
|
Mastectomy, Segmental | 1 | 2022 | 956 | 0.150 |
Why?
|
Gastroplasty | 1 | 2018 | 142 | 0.150 |
Why?
|
Microchip Analytical Procedures | 1 | 2016 | 29 | 0.140 |
Why?
|
Bronchi | 1 | 2020 | 840 | 0.140 |
Why?
|
Length of Stay | 3 | 2021 | 6308 | 0.140 |
Why?
|
Surgical Mesh | 1 | 2018 | 276 | 0.140 |
Why?
|
Lymph Nodes | 5 | 2021 | 3469 | 0.140 |
Why?
|
Anastomosis, Surgical | 1 | 2019 | 987 | 0.140 |
Why?
|
Constriction, Pathologic | 1 | 2019 | 1107 | 0.140 |
Why?
|
Lymphatic Metastasis | 4 | 2021 | 2914 | 0.130 |
Why?
|
Retrospective Studies | 10 | 2024 | 77426 | 0.130 |
Why?
|
Immunoglobulin Fragments | 1 | 2014 | 84 | 0.120 |
Why?
|
Pancreas | 1 | 2021 | 1686 | 0.120 |
Why?
|
Iodine Radioisotopes | 2 | 2014 | 1032 | 0.120 |
Why?
|
Pancreatectomy | 2 | 2016 | 804 | 0.120 |
Why?
|
Prosthesis Implantation | 1 | 2018 | 642 | 0.120 |
Why?
|
Tissue Distribution | 2 | 2014 | 2335 | 0.110 |
Why?
|
Zirconium | 1 | 2014 | 100 | 0.110 |
Why?
|
Validation Studies as Topic | 1 | 2013 | 159 | 0.110 |
Why?
|
CA-19-9 Antigen | 1 | 2013 | 111 | 0.110 |
Why?
|
Lung | 2 | 2022 | 9852 | 0.110 |
Why?
|
Humans | 24 | 2024 | 744220 | 0.110 |
Why?
|
Hybridomas | 1 | 2013 | 452 | 0.110 |
Why?
|
Treatment Outcome | 5 | 2024 | 63119 | 0.110 |
Why?
|
Lymphoma | 1 | 2021 | 1873 | 0.110 |
Why?
|
Cell Line, Tumor | 5 | 2016 | 16687 | 0.100 |
Why?
|
Antibodies, Bispecific | 1 | 2013 | 164 | 0.100 |
Why?
|
Mutation | 1 | 2014 | 29784 | 0.090 |
Why?
|
Early Detection of Cancer | 1 | 2022 | 3086 | 0.080 |
Why?
|
Survival Rate | 4 | 2016 | 12781 | 0.080 |
Why?
|
Antigens, Neoplasm | 1 | 2014 | 1987 | 0.070 |
Why?
|
Laparoscopy | 1 | 2018 | 2149 | 0.070 |
Why?
|
Single-Cell Analysis | 1 | 2016 | 2183 | 0.070 |
Why?
|
Prognosis | 5 | 2021 | 29050 | 0.060 |
Why?
|
Quality Improvement | 1 | 2020 | 3746 | 0.060 |
Why?
|
Female | 10 | 2022 | 380197 | 0.060 |
Why?
|
Preoperative Care | 1 | 2014 | 2246 | 0.060 |
Why?
|
Flow Cytometry | 1 | 2014 | 5974 | 0.060 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2014 | 2942 | 0.060 |
Why?
|
Neoplasms | 1 | 2012 | 21672 | 0.060 |
Why?
|
Data Collection | 1 | 2012 | 3340 | 0.050 |
Why?
|
Aged | 7 | 2022 | 163253 | 0.050 |
Why?
|
Lymph Node Excision | 2 | 2020 | 1256 | 0.050 |
Why?
|
Neoplasm Proteins | 1 | 2014 | 3703 | 0.050 |
Why?
|
Nanoparticles | 1 | 2013 | 1905 | 0.050 |
Why?
|
Prostatic Neoplasms | 2 | 2014 | 11074 | 0.050 |
Why?
|
Risk Factors | 2 | 2022 | 72280 | 0.050 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2016 | 1692 | 0.040 |
Why?
|
Thoracotomy | 1 | 2020 | 363 | 0.040 |
Why?
|
Follow-Up Studies | 3 | 2015 | 39045 | 0.040 |
Why?
|
Thoracic Surgery, Video-Assisted | 1 | 2020 | 273 | 0.040 |
Why?
|
Neoplasm Invasiveness | 2 | 2016 | 3614 | 0.040 |
Why?
|
Male | 8 | 2022 | 350027 | 0.040 |
Why?
|
Animals | 5 | 2014 | 168788 | 0.030 |
Why?
|
SEER Program | 1 | 2021 | 1508 | 0.030 |
Why?
|
Morbidity | 1 | 2020 | 1769 | 0.030 |
Why?
|
Mice | 4 | 2014 | 81178 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 2 | 2014 | 20123 | 0.030 |
Why?
|
GPI-Linked Proteins | 1 | 2014 | 434 | 0.030 |
Why?
|
Phenylthiohydantoin | 1 | 2014 | 192 | 0.030 |
Why?
|
Cystine | 1 | 2013 | 95 | 0.030 |
Why?
|
Prospective Studies | 2 | 2015 | 53280 | 0.030 |
Why?
|
X-Ray Microtomography | 1 | 2014 | 428 | 0.030 |
Why?
|
Isotope Labeling | 1 | 2014 | 414 | 0.030 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2016 | 602 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2016 | 1770 | 0.020 |
Why?
|
California | 1 | 2014 | 1402 | 0.020 |
Why?
|
Liposomes | 1 | 2013 | 758 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2020 | 2726 | 0.020 |
Why?
|
Protein Engineering | 1 | 2013 | 540 | 0.020 |
Why?
|
Nitriles | 1 | 2014 | 952 | 0.020 |
Why?
|
Benzamides | 1 | 2014 | 1378 | 0.020 |
Why?
|
Tumor Burden | 1 | 2014 | 1914 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2020 | 57768 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2016 | 4188 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2016 | 3474 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2016 | 6172 | 0.020 |
Why?
|
Androgen Antagonists | 1 | 2014 | 1361 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2024 | 9230 | 0.020 |
Why?
|
Artifacts | 1 | 2014 | 1903 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2016 | 4803 | 0.020 |
Why?
|
United States | 1 | 2012 | 69867 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2014 | 6535 | 0.010 |
Why?
|
Middle Aged | 4 | 2020 | 213367 | 0.010 |
Why?
|
Incidence | 1 | 2020 | 20945 | 0.010 |
Why?
|
Young Adult | 2 | 2020 | 56436 | 0.010 |
Why?
|
Biopsy | 1 | 2014 | 6757 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2014 | 8628 | 0.010 |
Why?
|
Genotype | 1 | 2016 | 12956 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 14726 | 0.010 |
Why?
|
Logistic Models | 1 | 2016 | 13409 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2016 | 19907 | 0.010 |
Why?
|
Disease Progression | 1 | 2014 | 13280 | 0.010 |
Why?
|
Immunotherapy | 1 | 2013 | 4440 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2014 | 18027 | 0.010 |
Why?
|
Multiple Myeloma | 1 | 2013 | 5180 | 0.010 |
Why?
|
Adult | 2 | 2020 | 214035 | 0.010 |
Why?
|
Cohort Studies | 1 | 2016 | 40559 | 0.010 |
Why?
|
Adolescent | 1 | 2020 | 85759 | 0.010 |
Why?
|
Time Factors | 1 | 2014 | 40063 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2014 | 13668 | 0.010 |
Why?
|
Concepts
(135)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(16)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_